Excitement over meme stocks has been effective in helping to send biotech penny stocks on wild moves higher. But as that trend continues to fade, names in this category are going to lean more on company-specific catalysts to move the needle. Those catalysts will include progress and updates regarding their candidates in the pipeline for Food and Drug Administration (FDA) approval.
It’s approval itself from this regulatory agency that enables these new therapies, treatments, and vaccines to become available for sale in the U.S. That’s why biotech investors watch these developments....More>>>